References
- 1. Chugh SS, Roth Ga, Gillum Rf, Mensah Ga, Global burden of atrial fibrillation in developed and developing nations, Glob Heart, 2014; 1: 11311910.1016/j.gheart.2014.01.004
- 2. Maisel Wh, Stevenson Lw, Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. AmJ Cardiol 2003; 6A: 2D-8D10.1016/S0002-9149(02)03373-8
- 3. Agency for Healthcare Research and Quality. Weighted national estimates. HCUP National Inpatient Sample, 2012
- 4. A.J Camm, G.YH Lip, R. De Caterina, et al., Actualizarea ghidului de management al fibrilaţiei atriale al Societãţii Europene de Cardiologie 2012, Romanian Journal of Cardiology, 2013, Vol. 23, No. 2, pg 66
- 5. C.W Yancy, M. Jessup, B. Bozkurt, et al., ACC/AHA/ICSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America, Circulation, 2017, https://doi.org/10.1161/CIR.0000000000000509, Circulation. 2017;10.1161/CIR.0000000000000509.2017
- 6. MR Cowie, S.D. Anker, J.G.F. Cleland, et al., Improving care for patients with acute heart failure, 2014,Oxford PharmaGenesis, ISBN 978-1-903539-12-5. Available online at: http://www.oxfordhealthpolicyforum.org/reports/acute-heart-failure/improving-care-for-patients-with-acute-heart-failure10.1002/ehf2.12021
- 7. V.L Roger, 2013, Epidemiology of Heart Failure, Circulation Research. 2013; 113: 646-659 http://circres.ahajournals.org/content/113/6/646.full10.1161/CIRCRESAHA.113.300268
- 8. A.L Bui, TB. Horwich, GC. Fonarow, Epidemiology and Risk Profile of Heart Failure, 2017, Nature reviews. Cardiology, 8.1 (2011): 30–41. PMC. Web.10.1038/nrcardio.2010.165
- 9. V. L Roger, et al, 2011, Heart Disease and Stroke Statistics--2011 Update: A Report from the American Heart Association. Circulation 123, e18–e209 (2011)10.1161/CIR.0b013e3182009701
- 10. K.L Kalon, L.Pinsky, W.B.Kannel, D.Levy, The epidemiology of heart failure: The Framingham Study, 1993, JACC Vol. 22. No. 4 (Supplement A) October 1 !893:6A43A https://www.ncbi.nlm.nih.gov/pubmed/837669810.1016/0735-1097(93)90455-A
- 11. SG Priori, C. Blomström-Lundqvist, A. Mazzanti, et al., Ghidurile ESC 2015 pentru managementul pacienţilor cu aritmii ventriculare şi prevenţia morţii subite cardiace Grupul Operativ pentru managementul pacienţilor cu aritmii ventriculare şi prevenţia morţii subite cardiace al Societăţii Europene de Cardiologie (ESC), Romanian Journal of Cardiology, Vol. 26, No. 4, 2016
- 12. Ts Tsang, Bj Gersh, Cp Appleton, et al., Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women, J Am Coll Cardiol, 2002; 9: 1636-1644.10.1016/S0735-1097(02)02373-2
- 13. YM Cha, MM Redfield, WK Shen, BJ Gersh, et al., Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle,2014, Circulation; 109:2839.10.1161/01.CIR.0000132470.78896.A815197156
- 14. F Buccelletti, Di Somma S, Iacomini P, et al., Assessment of baseline characteristics and risk factors among Emergency Department patients presenting with recent onset atrial fibrillation: a retrospective cohort study, 2014, Eur Rev Med Pharmacol Sci 2013; 17 Suppl 1: 22
- 15. C.-Y. Hu, C.-Y. Wang, J.-Y. Li, J. Ma, Z.-Q. Li, Relationship between atrial fibrillation and heart failure, 2016; 20: 4593-4600, European Review for Medical and Pharmacological Sciences, http://www.europeanreview.org/wp/wp-content/uploads/4593-4600-Relationshipbetween-atrial-fibrillation-and-heart-failure.pdf
- 16. TJ Wang, MG Larson, D Levy, et al., Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study, EJ Circulation, 2003 Jun 17; 107(23):2920-510.1161/01.CIR.0000072767.89944.6E12771006
- 17. Y Miyasaka, Barnes ME, Gersh BJ, et al., Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decade, Eur Heart J., 2006 Apr; 27(8):936-4110.1093/eurheartj/ehi69416399778
- 18. Lubitz, Steven A., Emelia J. Benjamin, Patrick T. Ellinor, Atrial Fibrillation in Congestive Heart Failure, Heart failure clinics, 6.2 (2010): 187–200. PMC. Web. 12 Nov. 201710.1016/j.hfc.2009.11.001289540520347787
- 19. Chatterjee S, Sardar P, Lichstein E, Mukherjee D, Aikat S., Pharmacologic rate versus rhythm-control strategies in at r i a l fibrillation: an updated comprehensive review and meta-analysis. Pacing Clin Electrophysiol 2013; 1: 122-133.10.1111/j.1540-8159.2012.03513.x22978656
- 20. Tadros R, Khairy P, Rouleau Jl, Talajic M, Guerra Pg, Roy D, Atrial fibrillation in heart failure: drug therapies for rate and rhythm control, Heart Fail Rev 2014; 3: 315-324.10.1007/s10741-013-9395-623690262
- 21. Heidenreich PA, Sahay A, Kapoor JR, Pham MX, Massie B, Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006, J Am Coll Cardiol. 2010; 56:362–36810.1016/j.jacc.2010.02.05320650356